Related Experiment Video

Updated: Aug 19, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

[Prevention of thrombosis in heart valve diseases]

B J Meyer1, J H Beer

  • 1Kardiologische Abteilung, Inselspital Bern.

Therapeutische Umschau. Revue Therapeutique
|February 20, 1999
PubMed

Insights

Patients with valvular heart disease face risks of thromboembolism and bleeding during anticoagulation. This review outlines strategies for preventing these complications and managing oral anticoagulation therapy.

Area of Science:

  • Cardiology
  • Hematology

Context:

  • Patients with native valvular heart disease and mechanical prosthetic heart valves are at high risk for chronic thromboembolic and bleeding complications during therapeutic anticoagulation.
  • Managing anticoagulation in these patients requires careful consideration of risks and benefits.

Purpose:

  • To discuss recommendations for preventing thromboembolic events and bleeding complications in patients with valvular heart disease undergoing anticoagulation.
  • To outline risk factors for thromboembolic events, indications, and intensity of antithrombotic therapy.
  • To address practical challenges in oral anticoagulation for this patient population.

Summary:

  • This review covers major chronic risks of thromboembolism and bleeding in patients with valvular heart disease on anticoagulation.
  • It details recommendations for prevention, including identifying risk factors, appropriate antithrombotic therapy indications and intensity, and practical management of oral anticoagulation.

Impact:

  • Provides guidance for clinicians on optimizing anticoagulation strategies in valvular heart disease.
  • Aims to reduce the incidence of thromboembolic and bleeding events, improving patient outcomes.
  • Facilitates better management of oral anticoagulation, enhancing patient safety and adherence.

More Related Videos

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves11:12

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves

Published on: October 17, 2013

In Vitro Thrombosis Test for Ventricular Assist Devices09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...